Cboe Files to List Staked Injective ETF From Canary Capital

Cboe Moves to Expand Staked Crypto ETF Offerings in the U.S.

The Chicago Board Options Exchange (Cboe) has filed to list a new staked crypto ETF — this time for Injective (INJ) — in partnership with Canary Capital. If approved, this would be the third staked altcoin ETF in the U.S., following the successful filings for staked Solana (SOL) and staked Ether (ETH) in June.

Cboe submitted a 19b-4 form on Monday, shortly after Canary Capital filed its S-1 registration with the SEC for the staked Injective ETF.

The fund is designed to generate staking rewards by validating transactions through an approved staking platform, with proceeds flowing back to investors.

SEC Review May Extend Into 2026

The filing comes amid a shift toward regulatory clarity around staking, especially after a May SEC decision confirming that staking does not violate securities laws. This ruling has opened the door for a new class of yield-generating digital asset ETFs.

The SEC has not yet acknowledged the Cboe or Canary filings. Once acknowledged, an initial response deadline will fall between 30 to 45 days, likely in September 2025, while the full review period could extend up to 240 days, placing a final decision around March 2026.

Staked Injective ETF May Boost INJ Token Exposure

Injective Protocol (INJ) could benefit significantly from this ETF. As a governance and utility token used for decentralized derivatives and finance applications, greater institutional exposure through an ETF could increase liquidity and visibility.

INJ is currently trading around $14.80, still down over 71% from its all-time high of $52 recorded in March 2024.

If ETF inflows follow the trend seen in other staked asset funds, Injective could gain momentum in both price and mainstream adoption.

Canary Capital Targets First-Mover Advantage

By targeting Injective, Canary Capital is positioning itself early in the next wave of altcoin ETF products, reflecting investor demand for more diversified and yield-generating blockchain exposure in regulated U.S. markets.

Disclaimer

This content is for informational purposes only and does not constitute financial, investment, or legal advice. Cryptocurrency trading involves risk and may result in financial loss.